Abstract
Advances in cross-sectional imaging have led to an increasingly important role for radiology in the management of malignant gynecological conditions. A number of imaging modalities can be used to evaluate malignant diseases of the female pelvis, including ultrasound (US), computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography/computed tomography (PET/CT). These modalities have different roles in screening, diagnosis, staging, treatment selection and follow-up. The aim of this chapter is to review the role of different techniques in the imaging of malignant gynecological conditions. The emphasis is on the use of MRI in the staging of endometrial and cervical cancer following the revised FIGO (International Federation of Gynecology and Obstetrics) criteria, implemented beginning June 1, 2009 [1].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Pecorelli S (2009) Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 105:103–104
Sala E, Wakely S, Senior E, Lomas D (2007) MRI of malignant neoplasms of the uterine corpus and cervix. AJR Am J Roentgenol 188:1577–1587
Shibutani O, Joja I, Shiraiwa M et al (1999) Endometrial carcinoma: efficacy of thin-section oblique axial MR images for evaluating cervical invasion. Abdom Imaging 24:520–526
Manfredi R, Mirk P, Maresca G et al (2004) Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning. Radiology 231:372–378
Sala E, Crawford R, Senior E et al (2009) Added value of dynamic contrast-enhanced magnetic resonance imaging in predicting advanced stage disease in patients with endometrial carcinoma. Int J Gynecol Cancer 19:141–146
Fujii S, Matsusue E, Kigawa J et al (2008) Diagnostic accuracy of the apparent diffusion coefficient in differentiating benign from malignant uterine endometrial cavity lesions: initial results. Eur Radiol 18:384–389
Shen SH, Chiou YY, Wang JH et al (2008) Diffusion-weighted single-shot echo-planar imaging with parallel technique in assessment of endometrial cancer. AJR Am J Roentgenol 190:481–488
Harry VN, Semple SI, Gilbert FJ, Parkin DE (2008) Diffusionweighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer. Gynecol Oncol 111:213–220
Fujii S, Matsusue E, Kanasaki Y et al (2008) Detection of peritoneal dissemination in gynecological malignancy: evaluation by diffusion-weighted MR imaging. Eur Radiol 18:18–23
Rockall AG, Sohaib SA, Harisinghani MG et al (2005) Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol 23:2813–2821
Ascher SM, Reinhold C (2002) Imaging of cancer of the endometrium. Radiol Clin North Am 40:563–576
Hricak H, Rubinstein LV, Gherman GM, Karstaedt N (1991) MR imaging evaluation of endometrial carcinoma: results of an NCI cooperative study. Radiology 179:829–832
Nicolet V, Carignan L, Bourdon F, Prosmanne O (2000) MR imaging of cervical carcinoma: a practical staging approach. Radiographics 20:1539–1549
Okamoto Y, Tanaka YO, Nishida M et al (2003) MR imaging of the uterine cervix: imaging-pathologic correlation. Radiographics 23:425–445
Scheidler J, Heuck AF (2002) Imaging of cancer of the cervix. Radiol Clin North Am 40:577–590,vii
Seki H, Takano T, Sakai K (2000) Value of dynamic MR imaging in assessing endometrial carcinoma involvement of the cervix. AJR Am J Roentgenol 175:171–176
Rockall AG, Ghosh S, Alexander-Sefre F et al (2006) Can MRI rule out bladder and rectal invasion in cervical cancer to help select patients for limited EUA? Gynecol Oncol 101:244–249
Hricak H, Gatsonis C, Chi DS et al (2005) Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183. J Clin Oncol 23:9329–9337
Mitchell DG, Snyder B, Coakley F et al (2006) Early invasive cervical cancer: tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651/GOG 183 Intergroup Study. J Clin Oncol 24:5687–5694
Subhas N, Patel PV, Pannu HK et al (2005) Imaging of pelvic malignancies with in-line FDG PET-CT: case examples and common pitfalls of FDG PET. Radiographics 25:1031–1043
Ricke J, Sehouli J, Hach C et al (2003) Prospective evaluation of contrast-enhanced MRI in the depiction of peritoneal spread in primary or recurrent ovarian cancer. Eur Radiol 13:943–949
Low RN, Duggan B, Barone RM et al (2005) Treated ovarian cancer: MR imaging, laparotomy reassessment, and serum CA-125 values compared with clinical outcome at 1 year. Radiology 235:918–926
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Verlag Italia
About this chapter
Cite this chapter
Sala, E., Ascher, S. (2010). Malignant Diseases of the Female Genital Tract. In: Hodler, J., Zollikofer, C.L., Von Schulthess, G.K. (eds) Diseases of the Abdomen and Pelvis 2010–2013. Springer, Milano. https://doi.org/10.1007/978-88-470-1637-8_17
Download citation
DOI: https://doi.org/10.1007/978-88-470-1637-8_17
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-1636-1
Online ISBN: 978-88-470-1637-8
eBook Packages: MedicineMedicine (R0)